BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37016911)

  • 21. Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis.
    Bansal S; Boucher R; Shen J; Wei G; Chertow GM; Whelton PK; Cushman WC; Cheung AK; Beddhu S;
    Clin J Am Soc Nephrol; 2024 May; 19(5):620-627. PubMed ID: 38262377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics.
    Tamargo J; Segura J; Ruilope LM
    Expert Opin Pharmacother; 2014 Mar; 15(4):527-47. PubMed ID: 24444254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients?
    Taber DJ; Srinivas TM; Pilch NA; Meadows HB; Fleming JN; McGillicuddy JW; Bratton CF; Thomas B; Chavin KD; Baliga PK; Egede LE
    Am J Nephrol; 2013; 38(4):285-91. PubMed ID: 24061145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents.
    Tamargo J; Segura J; Ruilope LM
    Expert Opin Pharmacother; 2014 Apr; 15(5):605-21. PubMed ID: 24456327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy and safety of diuretics in treating hypertension.
    Freis ED
    Ann Intern Med; 1995 Feb; 122(3):223-6. PubMed ID: 7810942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB; Jarvis B
    Drugs; 2002; 62(5):787-816. PubMed ID: 11929332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.
    Peterzan MA; Hardy R; Chaturvedi N; Hughes AD
    Hypertension; 2012 Jun; 59(6):1104-9. PubMed ID: 22547443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies.
    Tully PJ; Hanon O; Cosh S; Tzourio C
    J Hypertens; 2016 Jun; 34(6):1027-35. PubMed ID: 26886565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of indapamide with thiazide diuretics in patients with essential hypertension.
    Chalmers JP; Bune AJ; Graham JR; West MJ; Wing LM
    Med J Aust; 1981 Jul; 2(2):100-1. PubMed ID: 7300705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure.
    Naci H; Salcher-Konrad M; Dias S; Blum MR; Sahoo SA; Nunan D; Ioannidis JPA
    Br J Sports Med; 2019 Jul; 53(14):859-869. PubMed ID: 30563873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
    Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
    BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diuretic-induced hypokalaemia: an updated review.
    Lin Z; Wong LYF; Cheung BMY
    Postgrad Med J; 2022 Jun; 98(1160):477-482. PubMed ID: 33688065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension.
    Wellington K; Faulds DM
    Drugs; 2002; 62(13):1983-2005. PubMed ID: 12215069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of diuretics and risk of incident gout: a population-based case-control study.
    Bruderer S; Bodmer M; Jick SS; Meier CR
    Arthritis Rheumatol; 2014 Jan; 66(1):185-96. PubMed ID: 24449584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
    Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
    Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Patient Activation Interventions With or Without Financial Incentives to Promote Prescribing of Thiazides and Hypertension Control: A Randomized Clinical Trial.
    Kaboli PJ; Howren MB; Ishani A; Carter B; Christensen AJ; Vander Weg MW
    JAMA Netw Open; 2018 Dec; 1(8):e185017. PubMed ID: 30646291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Thiazide-Type Diuretics With Glycemic Changes in Hypertensive Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Zhang X; Zhao Q
    J Clin Hypertens (Greenwich); 2016 Apr; 18(4):342-51. PubMed ID: 26395424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.